B. Mark Evers, MD, FACS

Director, Markey Cancer Center
Director, Markey Cancer Center Affiliate Network
Physician in Chief of Oncology Service
Vice Dean for Academic Development, College of Medicine
Vice-Chair for Research, Department of Surgery

Clinical interests

  • Gastrointestinal Cancer
  • Gastrointestinal Physiology and Endocrinology
  • Gastrointestinal Surgery
  • Molecular Mechanisms of Normal Intestinal Development
  • Surgical Oncology

B. Mark Evers, MD, FACS

Director, Markey Cancer Center
Director, Markey Cancer Center Affiliate Network
Physician in Chief of Oncology Service
Vice Dean for Academic Development, College of Medicine
Vice-Chair for Research, Department of Surgery

Biography

My name is B. Mark Evers; I received my medical degree from the University of Tennessee Health Science Center, Memphis. I completed a surgical residency at the University of Louisville followed by a research fellowship at the University of Texas Medical Branch, Galveston.

I am board certified by the American Board of Surgery.

Faculty rank

Professor of Surgery

Education

Degree
University of Tennessee Health Science Center, Memphis

Residency
University of Louisville, School of Medicine

Fellowship
University of Texas Medical Branch, Galveston

Certifications or Special training
American Board of Surgery

Gastrointestinal Cancer

Multidisciplinary Clinic

Markey Cancer Center
Whitney-Hendrickson Building
First Floor
740 Rose St.
Lexington KY 40536-0098

HBCicon120x123
This is a clinic of the University of Kentucky Hospital, also known as UK Albert B. Chandler Hospital. Read more »



Melanoma (Skin Cancer)

Multidisciplinary Clinic

Markey Cancer Center
Whitney-Hendrickson Building
First Floor
740 Rose St.
Lexington KY 40536-0098

HBCicon120x123
This is a clinic of the University of Kentucky Hospital, also known as UK Albert B. Chandler Hospital. Read more »


UK HealthCare accepts many forms of insurance. See list of insurers »

 
  1. Vilchez V, Turcios L, Zaytseva Y, Stewart R, Lee EY, Maynard E, Shah MB, Daily MF, Tzeng CW, Davenport D, Castellanos AL, Krohmer S, Hosein PJ, Evers BM, Gedaly R.
    Cancer stem cell marker expression alone and in combination with microvascular invasion predicts poor prognosis in patients undergoing transplantation for hepatocellular carcinoma.
    Am J Surg. 2016 Aug;212(2):238-45.
  2. Yu T, Chen X, Lin T, Liu J, Li M, Zhang W, Xu X, Zhao W, Liu M, Napier DL, Wang C, Evers BM, Liu C.
    KLF4 deletion alters gastric cell lineage and induces MUC2 expression.
    Cell Death Dis. 2016;7(6):e2255.
  3. Upreti M, Jyoti A, Johnson SE, Swindell EP, Napier D, Sethi P, Chan R, Feddock JM, Weiss HL, O'Halloran TV, Evers BM.
    Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer.
    Oncotarget. 2016 May 19.
  4. Li J, Song J, Zaytseva YY, Liu Y, Rychahou P, Jiang K, Starr ME, Kim JT, Harris JW, Yiannikouris FB, Katz WS, Nilsson PM, Orho-Melander M, Chen J, Zhu H, Fahrenholz T, Higashi RM, Gao T, Morris AJ, Cassis LA, Fan TW, Weiss HL, Dobner PR, Melander O, Jia J, Evers BM.
    An obligatory role for neurotensin in high-fat-diet-induced obesity.
    Nature. 2016 May 19;533(7603):411-5.
  5. Sharma A, Haque F, Pi F, Shlyakhtenko LS, Evers BM, Guo P.
    Controllable self-assembly of RNA dendrimers.
    Nanomedicine. 2016 Apr;12(3):835-44.